Loading...
High levels of plasma homocysteine are associated with elevated risk for developing diabetic nephropathy, and B vitamins lower homocysteine levels. In a randomized controlled trial, Canadian investigators evaluated pharmacologic doses of combined B-vitamin therapy in 238 adults (75% men; 83% white) with type 1 or type 2 diabetes and known nephropathy; patients with advanced renal failure were excluded. Participants received daily supplements that contained folic acid (2.5 mg), vitamin B6 (25 mg), and vitamin B12 (1 mg), or placebo. Participants were assessed at baseline and at 18 and 36 months with radionuclide determinations of glomerular filtration rate (GFR). Secondary outcomes included adverse cardiovascular (CV) events such as stroke a…